Analysts Suggest MegaIPOs from SpaceX and OpenAI Could Indicate Market Peak Nifty 50 Volatility Index Drops Over 100 Points After Briefly Reclaiming 24000 Level Oil Price Reversal Highlights Persistent Geopolitical Risk Premium in Crude Markets Burberry Shares Jump on Speculation of Potential Moncler Acquisition Bid Lenovo Shares Surge Nearly 20 After Record Revenue and AI Revenue Nearly Doubles Wall Street Rallies Dow Jones Hits Record High on Middle East Ceasefire Hopes PTGX Q1 2026 Earnings Surprise Profitability Defies Estimates Amid No Revenue FIX Q1 2026 Earnings Massive EPS Beat of 5293 Surprises Market Algorhythm Holdings Inc RIME Q1 2026 Earnings EPS Surprises to the Upside Narrows Loss Significantly SurgePays Inc SURG Q4 2025 Earnings Significant EPS Miss Amid Challenging Quarter HBANP Q1 2026 Earnings Preferred Dividend Misses Estimates as Net Interest Margin Pressures Persist DHIL Q1 2025 Earnings EPS of 323 Reported Amidst Market Uncertainty Brightstar Lottery BRSL Holds Steady Assessing the Current Support and Resistance Structure RF Acquisition Corp III Units RFAMU Hovers Near Support Amid Modest Uptick RLI Corp RLI Treads Water Near Key Support as Insurance Sector Faces Headwinds Peabody Energy BTU Gains as Support Holds Amid Coal Sector Volatility Oxford Lane Capital Notes OXLCL Hold Steady Near Support Amid Rate Uncertainty Nvidia Earnings Could Be a Key Test for US Equities Amid Geopolitical Tensions After Xi Summit Airgain Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh Profusa Inc PFSA Facing Resistance at 038 as Shares Dip 321 ORLA Q1 2026 Earnings Narrow EPS Miss Pressures Shares Hour Loop Inc HOUR Q4 2024 Earnings Narrowing Losses in a Challenging Retail Environment SunCar Technology Group Inc Q4 2025 Earnings EPS Misses Estimates but Stock Surges on Optimism ALLY Q1 2026 Earnings EPS Beats Estimates by 1646 Stock Edges Up Chatham Lodging Trust CLDT Q1 2026 Earnings Narrowed Loss Beats Street Expectations Amid Challenging Conditions Offerpad Solutions Inc OPAD Q1 2026 Earnings Narrower Loss Beats Estimates as Cost Controls Drive Beat TNGX Q1 2026 Earnings ClinicalStage Biotech Reports Slight EPS Miss Stock Slips on No Revenue